Skip to main content
IMMUNOLOGY2026™ Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

  1. Home

  • Thursday, Apr 16th
    9:45 AM - 10:00 AM US ET
    Understanding unconventional T cell development to generate an ‘off the shelf’ immunotherapy to treat human diseases
    Location: 156
    Author: Daniel Pellicci, PhD – Murdoch Children's Research Institute
    Translational and Interventional Immunology (TI)
  • Thursday, Apr 16th
    9:45 AM - 11:15 AM US ET
    TI2 - Understanding immune responses to optimize immune intervention
    Location: 156
    Moderator: Eduardo Davila – University of Colorado, Denver
    Moderator: Juliet Williams – Kymera Therapeutics
    Translational and Interventional Immunology (TI)
  • Thursday, Apr 16th
    10:00 AM - 10:15 AM US ET
    Single-cell buoyant mass reveals CD8⁺ T-cell fitness and predicts melanoma checkpoint response
    Location: 156
    Author: JIAQUAN YU, PhD – Koch Inst. for Integrative Cancer Res., MIT
    Translational and Interventional Immunology (TI)
  • Thursday, Apr 16th
    10:15 AM - 10:30 AM US ET
    Single Cell Insights on Inflammation-Induced Transitional States in Benign Prostate Hyperplasia
    Location: 156
    Author: Nikhila T. Suresh, PhD (she/her/hers) – Florida Atlantic University
    Translational and Interventional Immunology (TI)
  • Thursday, Apr 16th
    10:30 AM - 10:45 AM US ET
    Optimizing Cancer Antibody Effectiveness: Pharmacology and Mathematical Modeling to Achieve Better Clinical Outcomes
    Location: 156
    Author: Denise Faustman, MD, PhD – Massachusetts General Hospital/Harvard Medical School
    Translational and Interventional Immunology (TI)
  • Thursday, Apr 16th
    10:45 AM - 11:00 AM US ET
    Morning influenza vaccination elicits superior antigen-specific immune responses in adults aged 60-85 years
    Location: 156
    Author: Tamara Brouwers, MSc (she/her/hers) – Dutch National Institute for Public Health and the Environment
    Translational and Interventional Immunology (TI)
  • Thursday, Apr 16th
    11:00 AM - 11:15 AM US ET
    BCG vaccine induces distinct metabolic shifts in monocytes in vitro and peripheral blood plasma in vivo: Implications for neonatal trained immunity
    Location: 156
    Author: Asimenia Angelidou, MD, PhD (she/her/hers) – Boston Children's Hosp., Harvard Med. Sch.
    Translational and Interventional Immunology (TI)
  • Friday, Apr 17th
    12:45 PM - 1:00 PM US ET
    Preliminary immunologic and clinical Phase 1b study outcomes from patients with ROSAH syndrome treated with the first-in-class ALPK1 inhibitor DF-003
    Location: 205
    Speaker: Neil Solomons, MB BS – Drug Farm
    Translational and Interventional Immunology (TI)
  • Friday, Apr 17th
    12:45 PM - 2:15 PM US ET
    TI4 - Interrogation of chronic immunity and interventional approaches
    Location: 205
    Moderator: Daniela Cipolletta, PhD – Seismic Therapeutic
    Moderator: Gerald Morris – University of California, San Diego
    Translational and Interventional Immunology (TI)
  • Friday, Apr 17th
    1:00 PM - 1:15 PM US ET
    Host HLA Allelic Variation Shapes Risk of Severe SARS-CoV-2 Infection and Long COVID
    Location: 205
    Author: Grace Kim, MS, PhD – Louisiana State University Health, New Orleans
    Translational and Interventional Immunology (TI)
  • Friday, Apr 17th
    1:15 PM - 1:30 PM US ET
    Discovery of potent, selective and insurmountable MRGPRX2 antagonists for mast cell-driven disorders
    Location: 205
    Author: Yves Millet, PhD – Blueprint Medicines Corporation
    Translational and Interventional Immunology (TI)
  • Friday, Apr 17th
    1:30 PM - 1:45 PM US ET
    Engineered Nanobodies for Durable Tolerance in Allergic Asthma
    Location: 205
    Author: Floris J. van Dalen, PhD – Boston Children's Hosp., Harvard Med. Sch.
    Translational and Interventional Immunology (TI)
  • Friday, Apr 17th
    1:45 PM - 2:00 PM US ET
    Persistent IL-17 Cytokine Patterns and Th17 Expansion Characterize Chronic Critical Illness after Severe Trauma
    Location: 205
    Author: Caleb Y. Kim, BS – University of Minnesota, Twin Cities
    Translational and Interventional Immunology (TI)
  • Friday, Apr 17th
    2:00 PM - 2:15 PM US ET
    Targeting the Adenosine–Adenosine Deaminase-1 Axis to Restore HIV-Specific CD8⁺ T Cell Function
    Location: 205
    Author: Arden O. Edgerton (she/her/hers) – Drexel University College of Medicine
    Translational and Interventional Immunology (TI)
  • Saturday, Apr 18th
    12:45 PM - 1:45 PM US ET
    TI7 - Adaptive T cell immunity in infection, vaccination, and neurodegeneration
    Location: 157
    Speaker: Allessandro Sette – La Jolla Inst. for Immunol
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    8:00 AM - 8:33 AM US ET
    From signal to strategy: Integrating biomarkers in clinical trials to accelerate drug development in transplant
    Location: 253
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    8:00 AM - 8:33 AM US ET
    From signal to strategy: Integrating biomarkers in clinical trials to accelerate drug development in transplant
    Location: 253
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    8:33 AM - 9:06 AM US ET
    Generative design of antibody Fc variants with synthetic and programmable immune function
    Location: 253
    Speaker: Sai Reddy – ETH Zurich
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    9:06 AM - 9:21 AM US ET
    Intranasal administration of a pan-reactive influenza antibody reveals Fc-independent mode of protection
    Location: 253
    Author: Faez Amokrane Nait Mohamed, PhD (he/him/his) – Harvard Medical School
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    9:21 AM - 9:54 AM US ET
    Engineering cytokine/antibody fusion proteins as targeted immunotherapeutics
    Location: 253
    Speaker: Jamie Spangler – Johns Hopkins Univ.
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    9:21 AM - 9:54 AM US ET
    Engineering cytokine/antibody fusion proteins as targeted immunotherapeutics
    Location: 253
    Speaker: Jamie Spangler – Johns Hopkins Univ.
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    9:54 AM - 10:09 AM US ET
    Targeted immunosuppression with a tissue-selective PD-1 agonist prevents rejection of transplanted hearts
    Location: 253
    Author: James A. Torchia, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    10:09 AM - 10:42 AM US ET
    Vitiligo treatment from the Bronze Age to the Age of Biologics: New hope for an ancient disease
    Location: 253
    Speaker: John E. Harris – Mass Gen. Brigham
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    10:09 AM - 10:42 AM US ET
    Vitiligo treatment from the Bronze Age to the Age of Biologics: New hope for an ancient disease
    Location: 253
    Speaker: John E. Harris – Mass Gen. Brigham
    Translational and Interventional Immunology (TI)
  • Sunday, Apr 19th
    10:42 AM - 11:15 AM US ET
    Decoding adaptive immunity
    Location: 253
    Speaker: Michael Birnbaum, PhD – MIT
    Translational and Interventional Immunology (TI)